ASCENTAGE PHARMA GROUP INTERNATIONAL
AAPG · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $96 | $40 | $37 | $36 |
| - Cash | $2 | $1 | $1 | $1 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $96 | $40 | $38 | $37 |
| Revenue | $0 | $0 | $1 | $0 |
| % Growth | 48.9% | -81% | 939% | – |
| Gross Profit | $0 | $0 | $1 | $0 |
| % Margin | 90.7% | 91.1% | 98.2% | 84.4% |
| EBITDA | -$1 | -$1 | $0 | -$0 |
| % Margin | -219.9% | -336.8% | 27.9% | -621.4% |
| Net Income | -$1 | -$1 | $0 | -$1 |
| % Margin | -252.8% | -362.3% | 19.8% | -660% |
| EPS Diluted | -1.73 | -1.82 | 0.55 | -1.8 |
| % Growth | 4.9% | -430.9% | 130.6% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |